This program aims to develop AI models and enter the U.S. market by utilizing medical data held by the Mayo Clinic Platform, one of the largest medical institutions in the world.

Selected for Phase 2 of HealthTech Gateway "AI Medical in the US," an acceleration program conducted by JETRO in collaboration with Mayo Clinic Platform
YStory Inc., a digital health startup specializing in menopausal care, has been selected for Phase 2 of the HealthTech Gateway "AI Medical in the US" program sponsored by the Japan External Trade Organization (JETRO). YStory Inc. Under this program, YStory aims to develop an AI model and enter the US market by utilizing medical data held by the Mayo Clinic Platform, one of the world's largest medical institutions.
Five AI-powered digital health companies, including YStory, have been selected for this program after a rigorous screening process by the Mayo Clinic Platform. Participating companies will have access to the Mayo Clinic Platform's millions of de-identified medical data and will have the opportunity to develop and validate their AI models. In addition, they will receive comprehensive support related to their entry into the U.S. market through expert one-on-one mentoring, feedback from clinical teams, and participation in pitch events for Mayo Clinic and the Minnesota ecosystem and investors.
YStory has developed its business as a digital healthcare startup that uses AI solutions to solve women's health problems around the world. In the U.S. market, patient characteristics, healthcare regulations, and insurance systems differ significantly from those in Japan. Through participation in this program, we aim to access the world's largest de-identified medical data and accelerate the development of AI algorithms for the diagnosis and treatment of menopause. We will also enhance our expertise in regulations and trends in the U.S. market to gain a foothold in overseas markets and advance to the next stage of business development.

Overview of the HealthTech Gateway "AI Medical in the US" Acceleration Program
This program is designed by JETRO (Japan External Trade Organization) in cooperation with the Ministry of Economy, Trade and Industry (METI) to support overseas expansion of domestic startup companies. This program will be developed in collaboration with the Mayo Clinic Platform, a top U.S. medical institution. The program aims to build evidence and market entry in the U.S. market through lecture sessions, workshops, and 1-on-1 mentoring.
In the foundation program (Phase 1), which began in October 2024, we have obtained knowledge acquisition and strategy development support for entering the U.S. healthcare market, as well as support for making local connections through visits to the Mayo Clinic Minnesota campus.
Japan External Trade Organization (JETRO) press release on Phase 1:https://www.jetro.go.jp/news/releases/2024/40d837331735cd42.html
The Medical Data Utilization Program (Phase 2), which will begin in January 2025, is a 30-week virtual program that will provide access to the Mayo Clinic Platform's medical data platform, support for the development and validation of AI models, and 1-on-1 mentoring with experts in the field. The program is a 30-week virtual program.
In April 2025, the project will travel to Minnesota, U.S., for a five-minute pitch at a DemoDay event and networking with Minnesota ecosystem stakeholders, among other opportunities for comprehensive support in entering the U.S. market.
Japan External Trade Organization (JETRO) press release on Phase 2:https://prtimes.jp/main/html/rd/p/000000226.000071241.html
About Japan External Trade Organization (JETRO)
JETRO aims to contribute to the further development of Japan's economy and society through trade and investment promotion and research on developing countries. The JETRO also contributes to Japan's corporate activities and trade policy through research and studies.
In recent years, in conjunction with the government's five-year plan for startup development, we have been strongly promoting support for startups' overseas expansion.
About YStory Inc.
We are developing a menopausal digital healthcare business using AI technology and medical science. JoyHer, a menopausal healthcare app that provides personalized care tips (advice) by tapping into daily symptoms and initiatives.
In the future, we aim to provide a one-stop platform for menopausal awareness, diagnosis, and treatment.
YStory Corporation|Company Profile
| name of company | YStory Inc. |
| Establishment | Jan. 2023 |
| Location | Nishi-Oi, Shinagawa-ku, Tokyo |
| representative | Janet Yu |
| uniform resouce locator | https://www.ystoryfemtech.com/ Official JoyHer application website:https://www.joyher.life/ |









